Want to join the conversation?
$GGP 2Q15 Call: Total sales would exclude anchor productivity, but accounts for all in line tenants regardless of suite size as we believe this is more meaningful barometer for not only the state of the customer, but also the quality of the portfolio plan to nearly $20.5Bil up 3.4% on a trailing 12-month comparison.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.